BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.2233
+0.0031 (1.41%)
Aug 14, 2026, 12:09 PM EDT - Market open
BioRestorative Therapies Revenue
BioRestorative Therapies had revenue of $23.17K in the quarter ending March 31, 2026, a decrease of -7.32%. This brings the company's revenue in the last twelve months to $357.87K, down -8.47% year-over-year. In the year 2025, BioRestorative Therapies had annual revenue of $359.70K, down -10.30%.
Revenue (ttm)
$357.87K
Revenue Growth
-8.47%
P/S Ratio
15.68
Revenue / Employee
$25,562
Employees
14
Market Cap
5.69M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 359.70K | -41.30K | -10.30% |
| Dec 31, 2024 | 401.00K | 255.20K | 175.03% |
| Dec 31, 2023 | 145.80K | 26.00K | 21.70% |
| Dec 31, 2022 | 119.80K | 73.80K | 160.43% |
| Dec 31, 2021 | 46.00K | -31.00K | -40.26% |
| Dec 31, 2020 | 77.00K | -53.00K | -40.77% |
| Dec 31, 2019 | 130.00K | 19.00K | 17.12% |
| Dec 31, 2018 | 111.00K | 30.00K | 37.04% |
| Dec 31, 2017 | 81.00K | 44.65K | 122.80% |
| Dec 31, 2016 | 36.36K | -592.56K | -94.22% |
| Dec 31, 2015 | 628.92K | 212.92K | 51.18% |
| Dec 31, 2014 | 416.00K | 414.32K | 24,661.67% |
| Dec 31, 2013 | 1.68K | -13.91K | -89.22% |
| Dec 31, 2012 | 15.59K | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| GeoVax Labs | 852.28K |
| CollPlant Biotechnologies | 389.00K |
| AIM ImmunoTech | 95.00K |
| Cardio Diagnostics Holdings | 14.45K |
| Soligenix | 2.34K |
| Ernexa Therapeutics | 1,000.00 |
BRTX News
- 7 weeks ago - BioRestorative Therapies completes manufacturing for BRTX-100 - TheFly
- 7 weeks ago - BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform - GlobeNewsWire
- 7 weeks ago - BioRestorative Therapies Slides: Corporate presentation - Filings
- 2 months ago - BioRestorative Therapies appoints Smith as VP of Biocosmeceuticals Division - TheFly
- 2 months ago - BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth - GlobeNewsWire
- 2 months ago - BioRestorative Therapies Slides: Corporate presentation - Filings
- 2 months ago - BioRestorative Therapies shareholder Kaos Capital acquires 4.9% stake - TheFly
- 2 months ago - Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX) - PRNewsWire